SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-005352
Filing Date
2022-04-05
Accepted
2022-04-05 07:10:36
Documents
15
Period of Report
2022-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20220331.htm   iXBRL 8-K 77734
2 EX-4.1 oncr-ex4_1.htm EX-4.1 122692
3 EX-10.1 oncr-ex10_1.htm EX-10.1 874846
4 EX-99.1 oncr-ex99_1.htm EX-99.1 26127
  Complete submission text file 0000950170-22-005352.txt   1369503

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20220331.xsd EX-101.SCH 2480
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20220331_pre.xml EX-101.PRE 10320
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20220331_lab.xml EX-101.LAB 13996
9 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20220331_htm.xml XML 4882
Mailing Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 22805178
SIC: 2834 Pharmaceutical Preparations